Differential inhibition of tumour cell-induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin (Q30453962)

19 October 2017

Differential inhibition of tumour cell-induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin (English)

1 reference

19 October 2017

1 reference

1 reference

Carlos Medina

1

1 reference

19 October 2017

Shona Harmon

2

1 reference

19 October 2017

Iwona Inkielewicz

3

1 reference

19 October 2017

Maria Jose Santos-Martinez

4

1 reference

19 October 2017

Michael Jones

5

1 reference

19 October 2017

Paula Cantwell

6

1 reference

19 October 2017

Despina Bazou

7

1 reference

19 October 2017

Mark Ledwidge

8

1 reference

19 October 2017

Marek W Radomski

9

1 reference

19 October 2017

John F Gilmer

10

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 June 2012

1 reference

British Journal of Pharmacology

19 October 2017

1 reference

19 October 2017

166

1 reference

19 October 2017

3

1 reference

19 October 2017

938-949

1 reference

Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?

19 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

Elucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

Aspirin intake and survival after breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

Aspirin use and survival after diagnosis of colorectal cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

Aspirin, salicylates, and cancer.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

Aspirin and cancer risk: a summary review to 2007.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

NO-donating NSAIDs and cancer: an overview with a note on whether NO is required for their action

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

Nitrates and NO-NSAIDs in cancer chemoprevention and therapy: in vitro evidence querying the NO donor functionality

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

NSAIDs and cancer prevention: targets downstream of COX-2.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

Regulation of platelet functions by P2 receptors

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

Nanoparticle-induced platelet aggregation and vascular thrombosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

Platelets and metastasis revisited: a novel fatty link

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

Platelet physiology and thrombosis.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

Platelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

Identification, characterization, and inhibition of the platelet ADP receptors

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

Integrin signaling: the platelet paradigm

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

Platelet prostanoid receptors

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

Adhesive receptors expressed by tumor cells and platelets: novel targets for therapeutic anti-metastatic strategies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

Cellular activation by thromboxane A2 and other eicosanoids

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417420

Isosorbide-based aspirin prodrugs: integration of nitric oxide releasing groups.

28 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2011.01794.X

Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer: a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2011.01794.X

Platelet aggregation-induced by caco-2 cells: regulation by matrix metalloproteinase-2 and adenosine diphosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2011.01794.X

Discovery of a "true" aspirin prodrug

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2011.01794.X

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2011.01794.X

The in vitro effects of niacin on platelet biomarkers in human volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2011.01794.X

Aspirin in the prevention of cancer

21 January 2018

1 reference

12 December 2020

Mechanisms of aggregation inhibition by aspirin and nitrate-aspirin prodrugs in human platelets

1 reference

12 December 2020

Adjuvant antiplatelet therapy with aspirin in colo-rectal cancer

1 reference

12 December 2020

An improved method for washing of human platelets with prostacyclin

1 reference

12 December 2020

Morphometric evaluation of thrombogenesis by microvesicles from human tumor cell lines with thrombin-dependent (U87MG) and adenosine diphosphate-dependent (SKNMC) platelet-activating mechanisms

1 reference

12 December 2020

Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets

1 reference

12 December 2020

Hemostasis and malignancy: an overview

1 reference

12 December 2020

No effect of an antiaggregant treatment with aspirin in small cell lung cancer treated with CCAVP16 chemotherapy. Results from a randomized clinical trial of 303 patients. The "Petites Cellules" Group

1 reference

12 December 2020

Studies on tumor-cell-induced platelet aggregation in human lung cancer cell lines

1 reference

12 December 2020

Protein kinase C delta mediates platelet-induced breast cancer cell invasion

1 reference

12 December 2020

P2 receptors, platelet function and pharmacological implications

1 reference

12 December 2020

10.1111/J.1476-5381.2011.01794.X

Identifiers

DOI

1 reference

19 October 2017

1 reference

19 October 2017

1 reference